Continued insulin dependence despite normal range insulin sensitivity and insulin connecting peptide levels in a kidney/islet transplant patient

Diabetes Care

Volumn 19, Issue 3, 1996, Pages 236-240

  Atkison, Paul R ^a,c   Zucker, Peter ^a   Hramiak, Irene ^a   Paul, Terri L ^a   Dupre, John ^a   Behme, Margaret T ^a   Scharp, David W ^b   Lacy, Paul E ^b   Olack, Barbera J ^b   Stiller, Calvin R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WASHINGTON UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INSULIN; MONOCLONAL ANTIBODY; OKT 3; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; KIDNEY TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; TREATMENT FAILURE;

EID: 9044248591     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.3.236     Document Type: Article

References (29)

1. Sollinger HW, Geffner SR: Pancreas transplantation. Surg Clin North Am 74:1183-1195, 1994
2. Canadian-European Randomized Control Trial Group: Cyclosporine-induced remission of IDDM after early intervention. Diabetes 37:1574-1582, 1988
3. Hramiak IM, Dupre J, Finegood DT: Determinants of clinical remission in recent-onset IDDM. Diabetes Care 16:125-132, 1993
4. Scharp DW, Lacy PE, Finke E, Olack BJ: Low temperature culture of human islets isolated by the distension method and purified with Ficoll or Percoll gradients. Surgery 102:869-879, 1987
5. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 37 413-420, 1988
6. Scharp DW, Lacy PE, Santiago JV, McCullough S, Weide LG, Falqui L, Marchetti P, Gingerich RL, Jaffe AS, Cryer PE, Anderson CB, Flye MW: Insulin independence after islet transplantation into type I diabetic patient. Diabetes 39:515-518, 1990
7. Rajotte RV, Warnock GL, Kneteman NM: Cryopreservation of insulin producing tissue in rats and dogs. World J Surg 8:179-186, 1984
8. Kneteman NM, Alderson D, Scharp DW, Lacy PE: Long-term cryogenic storage of purified adult human islets of Langerhans. Diabetes 38 386-396, 1989
9. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimations of insulin sensitivity. Am J Phys 236:E667, 1979
10. Welch S, Gebhart SSP, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 70:1508-1518, 1990
11. Finegood DT, Hramiak IM, Dupre J: A modified protocol for estimation of insulin sensitivity with the minimal-model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538-1549, 1990
12. Heding L: Radioimmunological determination of human C-peptide in serum. Diabetologia 2.541-548, 1975
13. Kuzuya H, Blix PM, Horwitx DL, Steiner DF, Rubenstein AH: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29, 1977
14. Parker KM, England JD, DaCosta J, Hess RI, Goldstein DE: Improved colorimetric assay for glycosylated hemoglobin. Clin Chem 27:669-672, 1981
15. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RLL, Jaffe AS, Cryer JPE, Hanto DW, Anderson CB, Flye MW: Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 51 76-85, 1991
16. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, Sands RE, Pei D, Savage PJ, Bergman RN for The Insulin Resistance Atherosclerosis Study: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
17. Guan J, Zucker PF, Atkison P, Behme MT, Dupre J, Stiller CR: Liver-omental pouch and intrahepatic islet transplants produce portal insulin delivery and prevent hyperinsulinemia in rats. Transplant Proc 27: 3236, 1995
18. Robertson RP, Kendall D, Teuscher A, Sutherland D: Long-term metabolic control with pancreatic transplantation. Transplant Proc 26:386-387, 1994
19. Christiansen E, Tibell A, Groth CG, Rasmussen K, Pedersen O, Burcharth F, Christensen NJ, Volund A, Madsbad S, the Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation: Limitations in the use of insulin or C-peptide alone in the assessment of B-cell function in pancreas. Transplant Proc 26: 467-468, 1994
20. Madsbad S, Christiansen E, Tibell A, Tyden G, Rasmussen K, Burcharth F, the Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation: Beta cell dysfunction following successful segmental pancreas transplantation. Transplant Proc 26:469-470, 1994
21. Barron P, Humar A, Davies J, Radziuk J: Insulin sensitivity and glucose tolerance following transposition of pancreatic venous drainage to the systemic circulation. Transplant Proc 26:487-489, 1994
22. Dupre J, Grace DM, McDonald TJ, Inculet R, Leblanc B: Pancreatic endocrine responses to nutrients and bombesin after segmental pancreas autotransplantation in dogs. Pancreas 2:99-105, 1987
23. van Suylichem PTR, Strubbe JH, Houving H, Wolters GHJ, van Schilfgaarde R Insulin secretion by rat islet isografts of a defined endocrine volume after transplantation to three different sites. Diabetologia 35 917-923, 1992
24. Williamson MP, Behme MT, Dupre J, Grant DR, Guan J, Zhong R: Rats with portal-caval vein transposition show hyperinsulinemia and insulin resistance. Metabolism 45:1-6, 1996
25. Guan J, Behme MT, Zucker PF, Dupre J, Stiller CR. Portal insulin delivery prevents hyperinsulinemia in rats with renal-mesenteric vein anastomosis after renal islet transplants Transplant Proc 37:3237, 1995
26. Volund A, Polonsky KS, Bergmen RN: Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics Diabetes 36: 1195-1202, 1987
27. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77: 98-105, 1986
28. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-984, 1993
29. Yki-Järvinen H, Koivisto VA: Natural course of insulin resistance in type I diabetes N Engl J Med 315.224-230, 1986